Jing Zhu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Jing Zhu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
Bihui Jin
Department of Reproductive Endocrinology, Reproductive Medicine Center Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College Hangzhou China
2 shared publications- Jie Song
Trauma Center, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu Province, China
1 shared publication Jing Shu
Department of Reproductive Endocrinology, Reproductive Medicine Center Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College Hangzhou China
1 shared publication- Jing Shu
Center for Reproductive Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
1 shared publication Ling Zhang
Department of Reproductive Endocrinology, Reproductive Medicine Center Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College Hangzhou China
1 shared publication- Liping Yang
Trauma Center, The First People's Hospital of Lianyungang, Lianyungang, Jiangsu Province, China
1 shared publication
Latest Publications
- Open Access
- 11 February 2023
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 49 (4) , 1173-1179
Elevated adipose differentiation‐related protein level in ovariectomized mice correlates with tissue‐specific regulation of estrogen
Objective: Redistribution of adipose tissue in the abdomen during the menopausal transition is attributable mostly to estrogen drop with aging. Adipose differentiation‐related protein (ADRP), a major component of lipid droplets, is closely related to the onset of lipid accumulation. We hypothesized that estrogen exerted its tissue‐specific effect in reducing abdominal fat accumulation by regulation of ADRP.Methods: Twenty‐four female C57/BL6 mice aged 8 weeks were randomly divided into 3 groups: sham operation (Sham), bilateral ovariectomy (OVX), and OVX plus 17β‐estradiol (OVX + E2). After being fed 8 weeks of a high‐fat diet, plasma lipid profiles including total cholesterol (TC), total triglyceride (TG), low‐density lipoprotein cholesterol (LDL‐C), and high‐density lipoprotein cholesterol (HDL‐C) levels, body weight gain, visceral, and subcutaneous adipose tissue, adipocyte size, and ADRP expression were measured.Results: In comparison to sham‐operated mice, OVX mice presented a weight gain with higher plasma TC, TG, LDL‐C levels, and lower HDL‐C levels. E2 supplement ameliorated the increase in weight and lipid profiles. Elevated ADRP expression was observed in visceral adipose tissue of OVX mice, whereas treatment of estrogen suppressed the ADPR expression and reversed the fat accumulation in the abdomen. However, no significant difference of ADRP expression in subcutaneous adipose tissue was detected between sham, OVX, and OVX + E2 mice.Conclusions: Our findings suggested that enhanced ADRP expression in ovariectomized mice correlates with the tissue‐specific regulation of estrogen, which may provide useful clues for further exploring the regulatory mechanism and corresponding anti‐abdominal obesity treatment in postmenopausal women.
- 11 February 2023
- Published by Wiley in Journal of Obstetrics and Gynaecology Research
- Vol. 49 (4) , 1173-1179
Open AccessElevated adipose differentiation‐related protein level in ovariectomized mice correlates with tissue‐specific regulation of estrogen
Objective: Redistribution of adipose tissue in the abdomen during the menopausal transition is attributable mostly to estrogen drop with aging. Adipose differentiation‐related protein (ADRP), a major component of lipid droplets, is closely related to the onset of lipid accumulation. We hypothesized that estrogen exerted its tissue‐specific effect in reducing abdominal fat accumulation by regulation of ADRP.Methods: Twenty‐four female C57/BL6 mice aged 8 weeks were randomly divided into 3 groups: sham operation (Sham), bilateral ovariectomy (OVX), and OVX plus 17β‐estradiol (OVX + E2). After being fed 8 weeks of a high‐fat diet, plasma lipid profiles including total cholesterol (TC), total triglyceride (TG), low‐density lipoprotein cholesterol (LDL‐C), and high‐density lipoprotein cholesterol (HDL‐C) levels, body weight gain, visceral, and subcutaneous adipose tissue, adipocyte size, and ADRP expression were measured.Results: In comparison to sham‐operated mice, OVX mice presented a weight gain with higher plasma TC, TG, LDL‐C levels, and lower HDL‐C levels. E2 supplement ameliorated the increase in weight and lipid profiles. Elevated ADRP expression was observed in visceral adipose tissue of OVX mice, whereas treatment of estrogen suppressed the ADPR expression and reversed the fat accumulation in the abdomen. However, no significant difference of ADRP expression in subcutaneous adipose tissue was detected between sham, OVX, and OVX + E2 mice.Conclusions: Our findings suggested that enhanced ADRP expression in ovariectomized mice correlates with the tissue‐specific regulation of estrogen, which may provide useful clues for further exploring the regulatory mechanism and corresponding anti‐abdominal obesity treatment in postmenopausal women.
- Top Cited PapersOpen Access
- 1 January 2023
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 14
Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective
Estrogen plays a prominent role in regulating and coordinating energy homeostasis throughout the growth, development, reproduction, and aging of women. Estrogen receptors (ERs) are widely expressed in the brain and nearly all tissues of the body. Within the brain, central estrogen via ER regulates appetite and energy expenditure and maintains cell glucose metabolism, including glucose transport, aerobic glycolysis, and mitochondrial function. In the whole body, estrogen has shown beneficial effects on weight control, fat distribution, glucose and insulin resistance, and adipokine secretion. As demonstrated by multiple in vitro and in vivo studies, menopause-related decline of circulating estrogen may induce the disturbance of metabolic signals and a significant decrease in bioenergetics, which could trigger an increased incidence of late-onset Alzheimer’s disease, type 2 diabetes mellitus, hypertension, and cardiovascular diseases in postmenopausal women. In this article, we have systematically reviewed the role of estrogen and ERs in body composition and lipid/glucose profile variation occurring with menopause, which may provide a better insight into the efficacy of hormone therapy in maintaining energy metabolic homeostasis and hold a clue for development of novel therapeutic approaches for target tissue diseases.
- 1 January 2023
- Published by SAGE Publications in Therapeutic Advances in Endocrinology and Metabolism
- Vol. 14
Top Cited PapersOpen AccessRole of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective
Estrogen plays a prominent role in regulating and coordinating energy homeostasis throughout the growth, development, reproduction, and aging of women. Estrogen receptors (ERs) are widely expressed in the brain and nearly all tissues of the body. Within the brain, central estrogen via ER regulates appetite and energy expenditure and maintains cell glucose metabolism, including glucose transport, aerobic glycolysis, and mitochondrial function. In the whole body, estrogen has shown beneficial effects on weight control, fat distribution, glucose and insulin resistance, and adipokine secretion. As demonstrated by multiple in vitro and in vivo studies, menopause-related decline of circulating estrogen may induce the disturbance of metabolic signals and a significant decrease in bioenergetics, which could trigger an increased incidence of late-onset Alzheimer’s disease, type 2 diabetes mellitus, hypertension, and cardiovascular diseases in postmenopausal women. In this article, we have systematically reviewed the role of estrogen and ERs in body composition and lipid/glucose profile variation occurring with menopause, which may provide a better insight into the efficacy of hormone therapy in maintaining energy metabolic homeostasis and hold a clue for development of novel therapeutic approaches for target tissue diseases.
- Open Access
- 25 September 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (39) , e22279
The effect of trauma care systems on the mortality of injured adult patients
Purpose: The aim of this study was to have a comprehensive evaluation of the effect of trauma care systems on the mortality of injured adult patients. Materials and methods: This protocol established in this study has been reported following the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols. Web of Science, PubMed, EMBASE, Scopus, and the Cochrane Library were searched for all clinical trials evaluating the effect of trauma care systems on the mortality of injured adult patients until July 31, 2020. We will use a combination of Medical Subject Heading and free-text terms with various synonyms to search based on the eligibility criteria. Two investigators independently reviewed the included studies and extracted relevant data. The odds ratio (OR) and 95% confidence intervals (CIs) were used as effect estimate. I-square (I2) test, substantial heterogeneity, sensitivity analysis, and publication bias assessment will be performed accordingly. Stata 15.0 and Review Manger 5.3 are used for meta-analysis and systematic review. Results: The results will be published in a peer-reviewed journal. Conclusion: The results of this review will be widely disseminated through peer-reviewed publications and conference presentations. This evidence may also provide a comprehensive evaluation of the effect of trauma care systems on the mortality of injured adult patients. Registration number: INPLASY202080058
- 25 September 2020
- Published by Wolters Kluwer Health in Medicine
- Vol. 99 (39) , e22279
Open AccessThe effect of trauma care systems on the mortality of injured adult patients
Purpose: The aim of this study was to have a comprehensive evaluation of the effect of trauma care systems on the mortality of injured adult patients. Materials and methods: This protocol established in this study has been reported following the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols. Web of Science, PubMed, EMBASE, Scopus, and the Cochrane Library were searched for all clinical trials evaluating the effect of trauma care systems on the mortality of injured adult patients until July 31, 2020. We will use a combination of Medical Subject Heading and free-text terms with various synonyms to search based on the eligibility criteria. Two investigators independently reviewed the included studies and extracted relevant data. The odds ratio (OR) and 95% confidence intervals (CIs) were used as effect estimate. I-square (I2) test, substantial heterogeneity, sensitivity analysis, and publication bias assessment will be performed accordingly. Stata 15.0 and Review Manger 5.3 are used for meta-analysis and systematic review. Results: The results will be published in a peer-reviewed journal. Conclusion: The results of this review will be widely disseminated through peer-reviewed publications and conference presentations. This evidence may also provide a comprehensive evaluation of the effect of trauma care systems on the mortality of injured adult patients. Registration number: INPLASY202080058